M&A activity in the life sciences space proceeded largely as usual in 2022, with most transactions receiving expected levels of agency scrutiny and closing in the normal course despite aggressive ...

Context is crucial in understanding the movement of any market, especially one as dynamic as life sciences. The $6B in total funding raised by life sciences and biotech startups in the U.S. in the ...

It’s hard to talk about individual well-being these days without talking about what’s going on in the world, whether that’s the mental health fallout of the COVID-19 pandemic, political polarization, ...